Microbiome Drug Development Summit
June 27 - 29, 2017 - Boston MA USHansonWade
info@hansonwade.com
Phone:+44 (0)20 3141 8700
Microbiome Drug Development Summit is the only end-to-end drug development meeting to help you tackle the challenges of developing microbiome-based therapeutics. Using insight gained from the most successful microbiome organizations across the globe, this forum helps emerging and well established companies discover, develop and deliver new generation of microbiome-based therapeutics. Microbiome Drug Development Summit will use industry case studies to develop your knowledge around four core areas of therapeutic advancement : • Scientific Activities- Translating microbiome data into a succesful health-care product • Clinical Activities- Obtaining decisive human data in a safe and timely manner • Regulatory Activities- Outlining clear regulatory paths that guarantee success • Financial Activities- Maximising shareholder value and sustaining growth Being part of Microbiome Drug Development Summit gives you the opportunity to get unprecedented access to the latest preclinical, clinical and commercial case studies from the brightest minds in biopharma and academia to turn microbiome discoveries of today into patient therapies of the future. Key Benefits of Attending: * Identify Druggable Targets for Microbiome-Therapeutic Development * Use Improved Preclinical Models for Drug Discovery * Design safe and effective Clinical Trials * Understand the expanding regulatory framework for Microbiome claims * Hear Novel Methods in Raising Investment to Accelerate Therapeutics Efforts